PeptideStack
5.2kquestions
20kanswers
220users

When does nausea stop being a tolerability issue and become a clinical one?

Asked 31 Oct 2025Modified 9 months agoViewed 2k times
10

I would rather spend on verification than on volume.

I want to decide this in advance so that I am not deciding it under pressure later.

Assume I will follow the plan I write down, so I would like it to be a good one.

What should I decide now, and what should I defer?

harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questionsgi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

416 questionspancreatitis
pancreatitis

Acute pancreatitis as a labelled risk: background incidence, the signal in pooled trial and pharmacovigilance data, lipase interpretation, and the…

14 questions
shareeditfollowflag
JF
askedjuliette_farnese12k2831 Oct 2025
3Does this hold at lower concentrations, or does adsorption dominate? – ines_brandt 6 months ago
2Worth flagging that this changed in 2025, so older answers on the site are out of date. – esther_vandeVelde 4 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 2k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.